Bayer AG (BAYRY)
7.60
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Bayer Enterprise Value: 64.35B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 64.35B |
| May 02, 2024 | 64.35B |
| May 01, 2024 | 63.41B |
| April 30, 2024 | 63.18B |
| April 29, 2024 | 63.69B |
| April 26, 2024 | 63.53B |
| April 25, 2024 | 63.06B |
| April 24, 2024 | 63.02B |
| April 23, 2024 | 63.45B |
| April 22, 2024 | 63.39B |
| April 19, 2024 | 62.31B |
| April 18, 2024 | 62.15B |
| April 17, 2024 | 62.21B |
| April 16, 2024 | 61.88B |
| April 15, 2024 | 62.07B |
| April 12, 2024 | 62.70B |
| April 11, 2024 | 63.29B |
| April 10, 2024 | 63.80B |
| April 09, 2024 | 63.88B |
| April 08, 2024 | 63.80B |
| April 05, 2024 | 64.16B |
| April 04, 2024 | 64.55B |
| April 03, 2024 | 65.06B |
| April 02, 2024 | 64.00B |
| April 01, 2024 | 64.55B |
| Date | Value |
|---|---|
| March 28, 2024 | 64.59B |
| March 27, 2024 | 64.63B |
| March 26, 2024 | 63.45B |
| March 25, 2024 | 63.14B |
| March 22, 2024 | 62.78B |
| March 21, 2024 | 62.66B |
| March 20, 2024 | 62.51B |
| March 19, 2024 | 61.96B |
| March 18, 2024 | 62.39B |
| March 15, 2024 | 62.55B |
| March 14, 2024 | 62.31B |
| March 13, 2024 | 62.98B |
| March 12, 2024 | 62.94B |
| March 11, 2024 | 63.21B |
| March 08, 2024 | 62.59B |
| March 07, 2024 | 62.78B |
| March 06, 2024 | 63.02B |
| March 05, 2024 | 62.27B |
| March 04, 2024 | 64.59B |
| March 01, 2024 | 64.63B |
| February 29, 2024 | 64.31B |
| February 28, 2024 | 64.90B |
| February 27, 2024 | 65.45B |
| February 26, 2024 | 64.83B |
| February 23, 2024 | 64.98B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.06B
Minimum
Dec 04 2023
121.14B
Maximum
Jan 23 2020
60.72B
Average
56.12B
Median
Jun 13 2022
Enterprise Value Benchmarks
| Affimed NV | 15.38M |
| InflaRx NV | -18.53M |
| MorphoSys AG | 2.633B |
| BioNTech SE | 4.294B |
| Immatics NV | 638.37M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.440B |
| Revenue (Quarterly) | 12.77B |
| Total Expenses (Quarterly) | 2.422B |
| EPS Diluted (Quarterly) | 0.3688 |
| Gross Profit Margin (Quarterly) | 62.18% |
| Profit Margin (Quarterly) | 11.27% |
| Earnings Yield | -10.88% |
| Operating Earnings Yield | 28.76% |
| Normalized Earnings Yield | -10.88 |